NAH... not a chance it's a new "avatar"
NAH... not a chance it's a new "avatar" embodiment...
there is something called style... people speak in certain patterns & also post in certain patterns.
Everyone who has read arvitar's posts can recognize a consistent style & theme to his posts.
Same can be said for others... some styles of posting are more easily recognized than others... some use certain words frequently, sometimes it is punctuation or formatting, sometimes it is content (like doing a lot of CUT & PASTE instead of making any comment, or repeating the same information day after day)...
a few familiar examples...
my posts have certain ways I state things... see any pattern I use in my posts?
4k has a style to her posts...
Village Pub has a distinctive post construction style...
glnetadm & gortclatu (Hubville) have distinctive styles...
and nanopatent (aka nano2win) who is a member of the Welland Three has a style & multiple aliases, too...
yet there is something that he frequently uses that he can be identified by once a post is "suspect" as being his...
and all posts begin to be examined to confirm the "style" marker occurs over and over.
There are some people (who read boards and yet seldom post) who actually are quite capable of identifying posters who change aliases from SMB to SMB -or- from time to time randomly! Many times (if not usually) the changes are for less-than-honest intentions!
For instance, a working JBI basher who has several aliases in Hubville can carry on a multiple post assault (& appear to be multiple posters) all by himself (yeah, not supposed to be possible... but it is done!) I suspect many of these multiple aliases get a "wink" in Hubville enforcement circles.
ALSO I know two examples from experience on that differing site's boards "way back when" that people not getting a "wink" from Hubville's Keystone Cops to operate as multiple-personalities were able to return under "new aliases" if Hubville booted them...
sometimes they were caught again quite quickly & rebooted, other times they survived quite a while by maintaining a slightly lower profile in posting and consciously using a different style (yes, Hubville ADMIN uses style comparison, too).
Both happened to be irritated shareholders (one owned JBII) & took great delight in forthrightly telling bashers in unflattering terms what they could do to themselves... which is the reason for the original bootings. Subsequent bootings were JUST BECAUSE they dared to sneak back in.
But I digress... lol... some will find this information to be shocking, & many might feel vindicated for suspecting the hypocrisy in Hubville even though they had no first-hand knowledge of such activity.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Neera Tanden Sets the Stage for 2027 When it comes to politics, everyone’s got their two cents, but Neera Tanden’s unpacking a whole piggy bank of progressive dreams. Set against the backdrop of a freshly reshuffled Congress post-midterms, she’s poised to dish out her roadmap for the future at the National Press Club on November 9. A Gathering of Minds This ain't...
Continue Reading
Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...
Continue Reading
Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...
Continue Reading
Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....
Continue Reading
Navigating Global Urban Challenges Amidst the backdrop of economic prowess and cultural diversity, the 2026 Global Mayors Dialogue in Ningbo has swiftly become a hotbed for city leaders hunting solutions. This wasn't your run-of-the-mill conference—mayors flocked from across the globe, all converging in this vibrant pocket of eastern China to unveil their visions for...
Continue Reading
Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...
Continue Reading
A Glimpse into Saudi's Ambitious Tourism Drive Ever feel like someone just decided to dominate the conversation at a global pow-wow? Well, that's the vibe Saudi Arabia brought to the World Travel Market (WTM) in London for 2026. With His Excellency Ahmed Al-Khateeb making headlines together with a mighty entourage of 37 tourism partners, the message was clear: Saudi...
Continue Reading
ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...
Continue Reading
Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...
Continue Reading
The New Era at Acuity Analytics Has Begun Isn't it something when a company decides to shake things up in such a daring way? Acuity Analytics just gave the financial sector a reason to sit up and pay attention. They've brought in Jon O'Donnell as the new Chief Executive Officer, a move that's got the city talking. O'Donnell is no rookie; he's a former IBM heavyweight and...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Contract Intelligence Market The contract intelligence market has become an essential component for organizations seeking to streamline their legal processes and optimize operational efficiency. Currently valued at over US$ 1,113.59 million, experts forecast that this market will grow substantially, surpassing US$ 7,212.65 million by 2033. This expected...
Continue Reading
Understanding the Growth Surge in Steel Stocks Recently, two prominent steel companies have garnered attention due to impressive growth metrics that show significant improvement. These advancements have reinforced their positions in the competitive steel market, indicating potential for further expansion. Vallourec SA: A Resilient Contender in Steel Production Vallourec...
Continue Reading
Turning the Election Tide in Illinois Damn, if you're not paying attention to what's shaking in Illinois, it's time to listen up. The Democrats under Speaker Emanuel "Chris" Welch are strutting their stuff, leaving an indelible mark on the political landscape. An eye-popping $35 million in campaign dough was raised, safeguarding every Democratic incumbent and managing to...
Continue Reading
Market Analysis of Roku's Stock Performance Concerns regarding Roku (NASDAQ: ROKU) have emerged as Morgan Stanley has lowered its price target for the stock to $60 from the previous $65. This decision comes despite the company experiencing a significant 35% surge in share prices following its Q2 2024 earnings report. The increase was fueled by expectations that the...
Continue Reading
Iterum Therapeutics Set to Shine at Global Investment Conference Iterum Therapeutics plc (Nasdaq: ITRM), headquartered in Dublin, Ireland, and Chicago, is a leading clinical-stage pharmaceutical company dedicated to developing next-generation oral antibiotics. These groundbreaking treatments are designed to combat infections caused by multi-drug resistant pathogens in...
Continue Reading